Compare Stocks: ARAY, ECOR, KEQU, and MBOT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARAY Accuray	$0.23 -2.0%	$0.26	$0.22 ▼ $2.10	$27.47M	1.39	427,094 shs	389,297 shs
ECOR electroCore	$11.42 -7.1%	$8.75	$4.41 ▼ $12.70	$110.81M	1	81,972 shs	113,311 shs
KEQU Kewaunee Scientific	$34.03 -0.2%	$36.38	$32.00 ▼ $46.57	$98.73M	0.73	4,104 shs	15,343 shs
MBOT Microbot Medical	$1.31 -5.1%	$1.59	$1.28 ▼ $3.74	$92.69M	1.03	451,514 shs	395,202 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARAY Accuray	-1.96%	-3.22%	-16.97%	-28.91%	-86.89%
ECOR electroCore	-7.08%	+7.23%	+18.34%	+58.83%	+120.89%
KEQU Kewaunee Scientific	-0.21%	-4.28%	-8.64%	-3.13%	-21.73%
MBOT Microbot Medical	-5.07%	-9.03%	-11.49%	-25.99%	-62.36%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARAY Accuray	$0.23 -2.0%	$0.26	$0.22 ▼ $2.10	$27.47M	1.39	427,094 shs	389,297 shs
ECOR electroCore	$11.42 -7.1%	$8.75	$4.41 ▼ $12.70	$110.81M	1	81,972 shs	113,311 shs
KEQU Kewaunee Scientific	$34.03 -0.2%	$36.38	$32.00 ▼ $46.57	$98.73M	0.73	4,104 shs	15,343 shs
MBOT Microbot Medical	$1.31 -5.1%	$1.59	$1.28 ▼ $3.74	$92.69M	1.03	451,514 shs	395,202 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARAY Accuray	-1.96%	-3.22%	-16.97%	-28.91%	-86.89%
ECOR electroCore	-7.08%	+7.23%	+18.34%	+58.83%	+120.89%
KEQU Kewaunee Scientific	-0.21%	-4.28%	-8.64%	-3.13%	-21.73%
MBOT Microbot Medical	-5.07%	-9.03%	-11.49%	-25.99%	-62.36%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARAY Accuray	1.67	Reduce	$2.00	786.92% Upside
ECOR electroCore	2.00	Hold	$18.00	57.62% Upside
KEQU Kewaunee Scientific	2.00	Hold	N/A	N/A
MBOT Microbot Medical	2.40	Hold	$6.38	386.64% Upside

Current Analyst Ratings Breakdown

Latest ARAY, ECOR, KEQU, and MBOT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/21/2026	ECOR electroCore	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/11/2026	MBOT Microbot Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$4.00
9/1/2026	ARAY Accuray	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/20/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/19/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/14/2026	MBOT Microbot Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$5.00 ➝ $4.00
8/4/2026	ARAY Accuray	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/22/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/14/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/8/2026	MBOT Microbot Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/8/2026	ARAY Accuray	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral

(Data available from 9/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARAY Accuray	$401.95M	0.07	N/A	N/A	$0.35 per share	0.64
ECOR electroCore	$36.97M	2.79	N/A	N/A	($0.21) per share	-54.38
KEQU Kewaunee Scientific	$282M	0.35	$5.94 per share	5.73	$26.67 per share	1.28
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$1.15 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARAY Accuray	-$49.19M	-$0.40	N/A	N/A	N/A	-12.24%	-97.85%	-10.82%	11/4/2026 (Estimated)
ECOR electroCore	-$13.97M	-$1.66	N/A	N/A	N/A	-39.96%	-1,956.38%	-81.35%	11/4/2026 (Estimated)
KEQU Kewaunee Scientific	$9.62M	$2.76	12.33	N/A	N/A	2.97%	11.61%	4.82%	N/A
MBOT Microbot Medical	-$13.14M	-$0.24	N/A	N/A	N/A	N/A	-21.87%	-20.76%	11/11/2026 (Estimated)

Latest ARAY, ECOR, KEQU, and MBOT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/9/2026	Q1 2027	KEQU Kewaunee Scientific	N/A	$0.58	N/A	$0.58	N/A	$66.32 million
8/19/2026	Q4 2026	ARAY Accuray	-$0.03	-$0.02	+$0.01	-$0.02	$105.30 million	$100.92 million
8/11/2026	Q2 2026	MBOT Microbot Medical	-$0.0767	-$0.08	-$0.0033	-$0.08	$0.13 million	$0.24 million
8/6/2026	Q2 2026	ECOR electroCore	-$0.4218	-$0.33	+$0.0918	-$0.33	$9.49 million	$9.45 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARAY Accuray	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARAY Accuray	3.51	1.50	0.74
ECOR electroCore	N/A	1.21	1.00
KEQU Kewaunee Scientific	0.51	2.20	1.57
MBOT Microbot Medical	N/A	18.56	17.82

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ARAY Accuray	64.08%
ECOR electroCore	26.74%
KEQU Kewaunee Scientific	32.69%
MBOT Microbot Medical	16.30%

Insider Ownership

Company	Insider Ownership
ARAY Accuray	2.40%
ECOR electroCore	7.80%
KEQU Kewaunee Scientific	14.10%
MBOT Microbot Medical	4.74%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ARAY Accuray	809	119.44 million	116.57 million	Optionable
ECOR electroCore	83	9.02 million	8.31 million	Not Optionable
KEQU Kewaunee Scientific	1,231	2.90 million	2.49 million	Not Optionable
MBOT Microbot Medical	22	67.17 million	63.98 million	Optionable

ARAY, ECOR, KEQU, and MBOT Headlines

Recent News About These Companies

Microbot Medical Inc. (NASDAQ:MBOT) Given Consensus Recommendation of "Hold" by Brokerages

September 23 at 5:00 AM | americanbankingnews.com

Microbot Medical Inc. (NASDAQ:MBOT) Given Average Rating of "Hold" by Analysts

September 23 at 4:28 AM | marketbeat.com

Microbot Medical stock trades near its yearly low

September 23 at 1:52 AM | ad-hoc-news.deA

Microbot Medical, Inc. Common Stock

September 21 at 5:52 PM | fxempire.comF

Microbot Medical stock gains analyst upgrade while fundamentals remain in focus

September 19, 2026 | ad-hoc-news.deA

Microbot Medical (NASDAQ:MBOT) Raised to "Sell" at Wall Street Zen

September 19, 2026 | americanbankingnews.com

Microbot Medical (NASDAQ:MBOT) Raised to Sell at Wall Street Zen

September 19, 2026 | marketbeat.com

B. Riley Financial Begins Coverage on Microbot Medical (NASDAQ:MBOT)

September 13, 2026 | americanbankingnews.com

Microbot Medical (NASDAQ:MBOT) Coverage Initiated at B. Riley Financial

September 11, 2026 | marketbeat.com

Wall Street Zen Downgrades Microbot Medical (NASDAQ:MBOT) to Strong Sell

September 5, 2026 | marketbeat.com

Microbot Medical Inc. (NASDAQ:MBOT) Receives Average Rating of "Hold" from Analysts

August 29, 2026 | marketbeat.com

Microbot Medical Inc.: Microbot Medical Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

August 11, 2026 | finanznachrichten.de

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

August 11, 2026 | markets.businessinsider.com

Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2026 | zacks.com

New Strong Buy Stocks for July 23rd

July 23, 2026 | zacks.com

Microbot Medical to Present on Endovascular Robotics at Society of Robotic Surgery Annual Meeting

July 21, 2026 | quiverquant.comQ

Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting

July 21, 2026 | globenewswire.com

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026

July 7, 2026 | globenewswire.com

Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

June 30, 2026 | globenewswire.com

Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

June 25, 2026 | globenewswire.com

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

June 23, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ARAY, ECOR, KEQU, and MBOT Company Descriptions

Accuray NASDAQ:ARAY

$0.23 0.00 (-1.96%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$0.23 +0.00 (+0.67%)

As of 07:05 AM Eastern

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

electroCore NASDAQ:ECOR

$11.42 -0.87 (-7.08%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$11.60 +0.18 (+1.53%)

As of 04:02 AM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Kewaunee Scientific NASDAQ:KEQU

$34.03 -0.07 (-0.21%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$34.03 +0.00 (+0.01%)

As of 04:02 AM Eastern

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

Microbot Medical NASDAQ:MBOT

$1.31 -0.07 (-5.07%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$1.30 -0.01 (-0.99%)

As of 07:41 AM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ARAY, ECOR, KEQU, and MBOT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ARAY, ECOR, KEQU, and MBOT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ARAY, ECOR, KEQU, and MBOT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ARAY, ECOR, KEQU, and MBOT Company Descriptions

Accuray NASDAQ:ARAY

electroCore NASDAQ:ECOR

Kewaunee Scientific NASDAQ:KEQU

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ARAY, ECOR, KEQU, and MBOT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ARAY, ECOR, KEQU, and MBOT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ARAY, ECOR, KEQU, and MBOT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ARAY, ECOR, KEQU, and MBOT Company Descriptions

Accuray NASDAQ:ARAY

electroCore NASDAQ:ECOR

Kewaunee Scientific NASDAQ:KEQU

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools